Philippe Gervois

Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation

Robert Kleemann, Lars Verschuren, Teake Kooistra, 2003 .

Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-α Activator Fenofibrate*

Robert Kleemann, Teake Kooistra, Wolfgang Koenig, 2004, Journal of Biological Chemistry.

Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–&agr; Activators: Clinical and Experimental Evidence

Alberto Zambon, B. Staels, P. Pauletto, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Virtual Screening of CB2 Receptor Agonists from Bayesian Network and High‐Throughput Docking: Structural Insights into Agonist‐Modulated GPCR Features

Philippe Chavatte, Pierre Desreumaux, Xavier Laurent, 2013, Chemical biology & drug design.

Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β*

Robert Kleemann, Teake Kooistra, T. Kooistra, 2001, The Journal of Biological Chemistry.

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity*

Bruno Derudas, Timothy M. Willson, L. Madsen, 2000, The Journal of Biological Chemistry.